Rasona, Maria Luz B.
HRN: 24-05-21 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/09/2023
CEFUROXIME 1.5GM (VIAL)
11/09/2023
11/10/2023
IVT
1.5 G
Q8
S/P Primary CS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes